MassDevice Q&A: GenomeQuest CEO Ron Ranauro
March 16, 2010 by Brad Perriello
CEO Ron Ranauro on GenomeQuest's customizable API, the falling cost of human genome sequencing and the ethical implications of widespread access to personal genome data.
Ron Ranauro spent the better part of two decades in the computer industry, watching as the personal computer and the Internet transformed the business. It's growing maturity coincided with early efforts to sequence the human genome, leading Ranauro in the late 1990s to apply his computing chops to the life science scene.
MassDevice spoke with Ranauro as GenomeQuest launched an application programming interface that allows developers to customize apps for their labs' research programs. We asked him about the API, what sets his venture apart from other sequencing data management firms (hint: it's in the clouds) and got his take on the ethical implications of widespread access to genome sequencing technology.
Business/Financial News, MassDevice Q&A, Data Management, Genomics/Molecular Diagnostics, Software / IT
Permalink
FDA Database Search
RECENT BLOG POSTS
- Funding R&D: High prices, overuse a failed strategy
- FDA's role in promoting women's health
- New partnership to boost use of GMDN codes for medical devices
- FDA's modern "Corps of Discovery" in China
- Consumers lose in latest FDA user fee bill; COI restraints disappear
- Gamification
- Cool technology of the week
- A new day: Interim thoughts on the 2012 Heart Rhythm Society scientific sessions
- When a child loses milestones, consider sleep EEG studies
- Red or blue pill for payment reform? Both won't work
Features
